The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Shilov Yu.E.

Mental Health Research Center

Miroshnichenko I.I.

Mental Health Research Center

Neopterin as a potential biomarker in neuropsychiatry

Authors:

Shilov Yu.E., Miroshnichenko I.I.

More about the authors

Read: 3676 times


To cite this article:

Shilov YuE, Miroshnichenko II. Neopterin as a potential biomarker in neuropsychiatry. S.S. Korsakov Journal of Neurology and Psychiatry. 2020;120(10):125‑129. (In Russ.)
https://doi.org/10.17116/jnevro2020120101125

Recommended articles:
Pathogenetic inte­rrelations of hypo­gonadism and depression in men. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):17-23
PANSS six-factor model. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):28-34
Clinical and immu­nological rela­tionships in patients with early schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):35-42
Clinical and psychopathological features of treatment-resistant schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):43-50
Pera­mpanel treatment in IQSEC2-associated epileptic ence­phalopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):143-149
The level of hypo­xia-induced factor-1a and asso­ciated mole­cules in preeclampsia. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):5-10

References:

  1. Miroshnichenko II. Ratsional’noe dozirovanie lekarstvennykh sredstv. Prakticheskoe rukovodstvo. M.: Izdatel’stvo «Meditsinskoe informatsionnoe agenstvo»; 2011. (In Russ.).
  2. Peng S, Li W, Lv L, Zhang Z, Zhan X. BDNF as a biomarker in diagnosis and evaluation of treatment for schizophrenia and depression. Discovery Medicine. 2018;26(143):127-136.  https://www.discoverymedicine.com/Shiyong-Peng/2018/10/bdnf-as-biomarker-in-diagnosis-and-treatment-for-schizophrenia-and-depression
  3. Bezrukov MV, Shilov IuE, Shestakova NV, Kliushnik TP. The biological evaluation of depression severity: a novel method for the determination of platelet serotonin concentration. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2014;114(8):51-57.  https://www.mediasphera.ru/issues/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova/2014/8/031997-7298201488/annotation
  4. Baymeeva NV, Miroshnichenko II. N-acetylaspartate is a biomarker of psychiatric and neurological disorders. Zhurnal Nevrologii i Psihiatrii im. S.S. Korsakova. 2015;115(8):94-98. (In Russ.). https://doi.org/10.17116/jnevro20151158194-98
  5. Yakovleva OB, Safarova TP, Miroshnichenko II, Platova AI. Gomotsistein pri depressii pozdnego vozrasta. Psikhiatriya. 2015;66(2):29-36. (In Russ.). https://www.journalpsychiatry.com/jour/article/view/28?locale=ru_RU
  6. Buckley PF. Neuroinflammation and Schizophrenia. Curr Psychiatry Rep. 2019;21(8):72.  https://doi.org/10.1007/s11920-019-1050-z
  7. Nardecchia F, Chiarotti F, Carducci C, Santagata S, Valentini G, Angeloni A, Blau N, Leuzzi V. Altered tetrahydrobiopterin metabolism in patients with phenylalanine hydroxylase deficiency. Eur J Pediatr. 2017;176(7):917-924.  https://doi.org/10.1007/s00431-017-2932-x
  8. Werner ER, Blau N, Thony B. Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem J. 2011;438:397-414.  https://doi.org/10.1042/BJ20110293
  9. Sviridov EA, Telegina TA. Neopterin i ego vosstanovlennye formy: biologicheskaya rol’ i uchastie v kletochnom immunitete. Uspekhi biologicheskoi Khimii. 2005;45:355-390. (In Russ.). https://www.fbras.ru/wp-content/uploads/2017/10/sviridov.pdf
  10. Michalak L, Bulska M, Strząbała K, Szcześniak P. Neopterin as a marker of cellular immunological response. Postepy Hig Med Dosw. 2017;71(1):727-736.  https://doi.org/10.5604/01.3001.0010.3851
  11. Murr C, Widner B, Wirleitner B, Fuchs D. Neopterin as a marker for immune system activation. Curr Drug Metab. 2002;3(2):175-187.  https://doi.org/10.2174/1389200024605082
  12. Isci Bostanci E, Ugras Dikmen A, Girgin G, Gungor T, Baydar T, Nuri Danisman A. A New Diagnostic and Prognostic Marker in Endometrial Cancer. Neopterin Int J Gynecol Cancer. 2017;27(4):754-758.  https://doi.org/10.1097/IGC.0000000000000952
  13. Carey BS, Jain R, Adams CL, Wong KY, Shaw S, Tse WY, Kaminski ER. Serum neopterin as an indicator of increased risk of renal allograft rejection. Transpl Immunol. 2013;28(2-3):81-85.  https://doi.org/10.1016/j.trim.2013.02.001
  14. Parker DC, Mielke MM, Yu Q, Rosenberg PB, Jain A, Lyketsos CG, Fedarko NS, Oh ES. Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer’s disease. Int J Geriatr Psychiatry. 2013;28(2):149-154.  https://doi.org/10.1002/gps.3802
  15. Blasko I, Knaus G, Weiss E, Kemmler G, Winkler C, Falkensammer G, Griesmacher A, Würzner R, Marksteiner J, Fuchs D. Cognitive deterioration in Alzheimer’s disease is accompanied by increase of plasma neopterin. J Psychiatr Res. 2007;41(8):694-701.  https://doi.org/10.1016/j.jpsychires.2006.02.001
  16. Schennach H, Murr C, Gächter E, Mayersbach P, Schönitzer D, Fuchs D. Factors influencing serum neopterin concentrations in a population of blood donors. Clin Chem. 2002;48(4):643-645.  https://clinchem.aaccjnls.org/content/48/4/643
  17. Müller N. Immunology of major depression. Neuroimmunomodulation. 2014;21(2-3):123-130.  https://doi.org/10.1159/000356540
  18. Kalkman HO, Feuerbach D. Antidepressant therapies inhibit inflammation and microglial M1-polarization. Pharmacol Ther. 2016;163:82-93.  https://doi.org/10.1016/j.pharmthera.2016.04.001
  19. Müller N, Weidinger E, Leitner B, Schwarz MJ. The role of inflammation in schizophrenia. Front Neurosci. 2015;9:372.  https://doi.org/10.3389/fnins.2015.00372
  20. Anderson G, Maes M. Bipolar disorder: role of immune-inflammatory cytokines, oxidative and nitrosative stress and tryptophan catabolites. Curr Psychiatry Rep. 2015;17(2):8.  https://doi.org/10.1007/s11920-014-0541-1
  21. Cristiano C, Lama A, Lembo F, Mollica MP, Calignano A, Mattace Raso G. Interplay Between Peripheral and Central Inflammation in Autism Spectrum Disorders: Possible Nutritional and Therapeutic Strategies. Front Physiol. 2018;9:184.  https://doi.org/10.3389/fphys.2018.00184
  22. Klyushnik TP, Androsova LV, Zozulya SA, Otman IN, Nikitina VB, Vetlugina TP. Sravnitel’nyi analiz vospalitel’nykh markerov pri endogennykh i nepsikhoticheskikh psikhicheskikh rasstroistvakh. Sibirskii Vestnik Psikhiatrii i Narkologii. 2018;99(2):64-69. (In Russ.). https://doi.org/10.26617/1810-3111-2018-2(99)-64-69
  23. Vancassel S, Capuron L, Castanon N. Brain Kynurenine and BH4 Pathways: Relevance to the Pathophysiology and Treatment of Inflammation-Driven Depressive Symptoms. Front Neurosci. 2018;12:499.  https://doi.org/10.3389/fnins.2018.00499
  24. McHugh PC, Joyce PR, Deng X, Kennedy MA. A polymorphism of the GTP-cyclohydrolase I feedback regulator gene alters transcriptional activity and may affect response to SSRI antidepressants. Pharmacogenomics J. 2011;11(3):207-213.  https://doi.org/10.1038/tpj.2010.23
  25. McHugh PC, Joyce PR, Kennedy MR. Polymorphisms of sepiapterin reductase gene alter promoter activity and may influence risk of bipolar disorder. Pharmacogenet. Genomics. 2009;19(5):330-337. 
  26. Kalkman HO, Feuerbach D. Antidepressant therapies inhibit inflammation and microglial M1-polarization. Pharmacol Ther. 2016;163:82-93.  https://doi.org/10.1016/j.pharmthera.2016.04.001
  27. Celik C, Erdem M, Cayci T, Ozdemir B, Ozgur Akgul E, Kurt YG, Yaman H, Isintas M, Ozgen F, Ozsahin A. The association between serum levels of neopterin and number of depressive episodes of major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(2):372-375.  https://doi.org/10.1016/j.pnpbp.2010.01.002
  28. Tang CZ, Zhang YL, Wang WS, Li WG, Shi P. Elevated Serum Levels of Neopterin at Admission Predicts Depression After Acute Ischemic Stroke: a 6-Month Follow-Up Study. Mol Neurobiol. 2016;53(5):3194-3204. https://doi.org/10.1007/s12035-015-9220-4
  29. Millett CE, Mukherjee D, Reider A, Can A, Groer M, Fuchs D, Postolache TT, Kelleher SL, Saunders EFH. Peripheral zinc and neopterin concentrations are associated with mood severity in bipolar disorder in a gender-specific manner. Psychiatry Res. 2017;255:52-58.  https://doi.org/10.1016/j.psychres.2017.05.022
  30. Korte S, Arolt V, Peters M, Weitzsch C, Rothermundt M, Kirchner H. Increased serum neopterin levels in acutely ill and recovered schizophrenic patients. Schizophr Res. 1998;32(1):63-67.  https://doi.org/10.1016/s0920-9964(98)00037-1
  31. Chittiprol S, Venkatasubramanian G, Neelakantachar N, Babu SV, Reddy NA, Shetty KT, Gangadhar BN. Oxidative stress and neopterin abnormalities in schizophrenia: a longitudinal study. J Psychiatr Res. 2010;44(5):310-313.  https://doi.org/10.1016/j.jpsychires.2009.09.002
  32. Kuehne LK, Reiber H, Bechter K, Hagberg L, Fuchs D. Cerebrospinal fluid neopterin is brain-derived and not associated with blood-CSF barrier dysfunction in non-inflammatory affective and schizophrenic spectrum disorders. J Psychiatr Res. 2013;47(10):1417-1422. https://doi.org/10.1016/j.jpsychires.2013.05.027
  33. Bodur S, Ceylan MF, Iseri E, Sener S, Yucel AA. Serum neopterin levels in patients with autism. International Journal of Developmental Disabilities. 2014;60(2):109-115.  https://doi.org/10.1179/2047387713Y.0000000029
  34. Garcia Garcia I, González-Delgado CA, Valenzuela-Silva CM, Díaz-Machado A, Cruz-Díaz M, Nodarse-Cuní H, Pérez-Pérez O, Bermúdez-Badell CH, Ferrero-Bibilonia J, Páez-Meireles R, Bello-Rivero I, Castro-Odio FR, López-Saura PA. Pharmacokinetic and pharmacodynamic comparison of two «pegylated» interferon alpha-2 formulations in healthy male volunteers: a randomized, crossover, double-blind study. BMC Pharmacology. 2010;10:15-25.  https://doi.org/10.1186/1471-2210-10-15
  35. Kranaster L, Hoyer C, Aksay SS, Bumb JM, Müller N, Zill P, Schwarz MJ, Moll N, Lutz B, Bindila L, Zerr I, Schmitz M, Blennow K, Zetterberg H, Haffner D, Leifheit-Nestler M, Ozbalci C, Janke C, Thiel M, Sartorius A. Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study. Neuropsychobiology. 2019;77(1):13-22.  https://doi.org/10.1159/000491401
  36. Hagberg L, Dotevall L, Norkrans G, Wachter H, Fuchs D. Cerebrospinal fluid neopterin concentrations in central nervous system infection. J Infect Dis. 1993;168:1285-1288. https://doi.org/10.1093/infdis/168.5.1285
  37. Hammerer-Lercher A, Moser C, Leichtfried V, Schobersberger W, Griesmacher A, Fuchs D. Comparison of a commercial urinary neopterin radioimmunoassay with high performance liquid chromatography. Clin Chem Lab Med. 2012;50(6):1075-1078. https://doi.org/10.1515/cclm-2011-0861
  38. Krcmova L, Solichova D, Melichar B, Kasparova M, Plisek J, Sobotka L, Solich P. Determination of neopterin, kynurenine, tryptophan and creatinine in human serum by high throuput HPLC. Talanta. 2011;85(3):1466-1471. https://doi.org/10.1016/j.talanta.2011.06.027
  39. Fuertig R, Ceci A, Camus SM, Bezard E, Luippold AH, Hengerer B. LC-MS/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brain. Bioanalysis. 2016;8(18):1903-1917. https://doi.org/10.4155/bio-2016-0111
  40. Whiley L, Nye LC, Grant I, Andreas N, Chappell KE, Sarafian MH, Misra R, Plumb RS, Lewis MR, Nicholson JK, Holmes E, Swann JR, Wilson ID. Ultrahigh-Performance Liquid Chromatography Tandem Mass Spectrometry with Electrospray Ionization Quantification of Tryptophan Metabolites and Markers of Gut Health in Serum and Plasma-Application to Clinical and Epidemiology Cohorts. Anal Chem. 2019;91(8):5207-5216. https://doi.org/10.1021/acs.analchem.8b05884

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.